DOI QR코드

DOI QR Code

The activation of NLRP3 inflammasome potentiates the immunomodulatory abilities of mesenchymal stem cells in a murine colitis model

  • Ahn, Ji-Su (Department of Life Science in Dentistry, School of Dentistry, Pusan National University) ;
  • Seo, Yoojin (Dental and Life Science Institute, Pusan National University) ;
  • Oh, Su-Jeong (Department of Life Science in Dentistry, School of Dentistry, Pusan National University) ;
  • Yang, Ji Won (Department of Life Science in Dentistry, School of Dentistry, Pusan National University) ;
  • Shin, Ye Young (Department of Life Science in Dentistry, School of Dentistry, Pusan National University) ;
  • Lee, Byung-Chul (Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University) ;
  • Kang, Kyung-Sun (Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University) ;
  • Sung, Eui-Suk (Department of Otorhinolaryngology, Head and Neck Surgery, Pusan National University Yangsan Hospital) ;
  • Lee, Byung-Joo (Department of Otorhinolaryngology-Head and Neck Surgery, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • Mohammadpour, Hemn (Department of Immunology, Roswell Park Comprehensive Cancer Center) ;
  • Hur, Jin (Department of Convergence Medicine, Pusan National University School of Medicine) ;
  • Shin, Tae-Hoon (Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health) ;
  • Kim, Hyung-Sik (Department of Life Science in Dentistry, School of Dentistry, Pusan National University)
  • Received : 2020.03.31
  • Accepted : 2020.04.30
  • Published : 2020.06.30

Abstract

Inflammasomes are cytosolic, multiprotein complexes that act at the frontline of the immune responses by recognizing pathogen- or danger-associated molecular patterns or abnormal host molecules. Mesenchymal stem cells (MSCs) have been reported to possess multipotency to differentiate into various cell types and immunoregulatory effects. In this study, we investigated the expression and functional regulation of NLR Family Pyrin Domain Containing 3 (NLRP3) inflammasome in human umbilical cord blood-derived MSCs (hUCB-MSCs). hUCB-MSCs expressed inflammasome components that are necessary for its complex assembly. Interestingly, NLRP3 inflammasome activation suppressed the differentiation of hUCB-MSCs into osteoblasts, which was restored when the expression of adaptor proteins for inflammasome assembly was inhibited. Moreover, the suppressive effects of MSCs on T cell responses and the macrophage activation were augmented in response to NLRP3 activation. In vivo studies using colitic mice revealed that the protective abilities of hUCB-MSCs increased after NLRP3 stimulation. In conclusion, our findings suggest that the NLRP3 inflammasome components are expressed in hUCB-MSCs and its activation can regulate the differentiation capability and the immunomodulatory effects of hUCB-MSCs.

Keywords

References

  1. Akira S, Uematsu S and Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124, 783-801 https://doi.org/10.1016/j.cell.2006.02.015
  2. Beutler B, Eidenschenk C, Crozat K et al (2007) Genetic analysis of resistance to viral infection. Nat Rev Immunol 7, 753-766 https://doi.org/10.1038/nri2174
  3. Hoffmann JA (2003) The immune response of Drosophila. Nature 426, 33-38 https://doi.org/10.1038/nature02021
  4. Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449, 819-826 https://doi.org/10.1038/nature06246
  5. Kato H, Takahasi K and Fujita T (2011) RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol Rev 243, 91-98 https://doi.org/10.1111/j.1600-065X.2011.01052.x
  6. Kawai T and Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650 https://doi.org/10.1016/j.immuni.2011.05.006
  7. Janeway CA Jr (1989) Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54 Pt 1, 1-13 https://doi.org/10.1101/SQB.1989.054.01.003
  8. van den Berk LC, Jansen BJ, Siebers-Vermeulen KG et al (2009) Toll-like receptor triggering in cord blood mesenchymal stem cells. J Cell Mol Med 13, 3415-3426 https://doi.org/10.1111/j.1582-4934.2009.00653.x
  9. Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES and Scandurro AB (2008) Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26, 99-107 https://doi.org/10.1634/stemcells.2007-0563
  10. Lombardo E, DelaRosa O, Mancheno-Corvo P, Menta R, Ramirez C and Buscher D (2009) Toll-like receptor-mediated signaling in human adipose-derived stem cells: implications for immunogenicity and immunosuppressive potential. Tissue Eng Part A 15, 1579-1589 https://doi.org/10.1089/ten.tea.2008.0340
  11. Kim HS, Shin TH, Yang SR et al (2010) Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood. PLoS One 5, e15369 https://doi.org/10.1371/journal.pone.0015369
  12. Hwa Cho H, Bae YC and Jung JS (2006) Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 24, 2744-2752 https://doi.org/10.1634/stemcells.2006-0189
  13. Vajjhala PR, Mirams RE and Hill JM (2012) Multiple binding sites on the pyrin domain of ASC protein allow selfassociation and interaction with NLRP3 protein. J Biol Chem 287, 41732-41743 https://doi.org/10.1074/jbc.M112.381228
  14. Martina P, Motti G, Peter DM, John CR and Stefan JR (2013) The CARD plays a critical role in ASC foci formation and inflammasome signalling. Biochem J 449, 613-621 https://doi.org/10.1042/BJ20121198
  15. Broderick L, De Nardo D, Franklin BS, Hoffman HM and Latz E (2015) The inflammasomes and autoinflammatory syndromes. Ann Rev Pathol 10, 395-424 https://doi.org/10.1146/annurev-pathol-012414-040431
  16. Bauernfeind FG, Horvath G, Stutz A et al (2009) Cutting edge: NF-${\kappa}B$ activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183, 787-791 https://doi.org/10.4049/jimmunol.0901363
  17. Yu J, Nagasu H, Murakami T et al (2014) Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy. Proc Natl Acad Sci U S A 111, 15514-15519 https://doi.org/10.1073/pnas.1414859111
  18. Kim SM, Ha JS, Han AR, Cho SW and Yang SJ (2019) Effects of $\alpha$-lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation. BMB Rep 52, 613-618 https://doi.org/10.5483/bmbrep.2019.52.10.026
  19. Augello A, Tasso R, Negrini SM, Cancedda R and Pennesi G (2007) Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen induced arthritis. Arthritis Rheum 56, 1175-1186 https://doi.org/10.1002/art.22511
  20. Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D and Delgado M (2009) Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136, 978-989 https://doi.org/10.1053/j.gastro.2008.11.041
  21. Le Blanc K, Rasmusson I, Sundberg B et al (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441 https://doi.org/10.1016/S0140-6736(04)16104-7
  22. Lee RH, Seo MJ, Reger RL et al (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 103, 17438 https://doi.org/10.1073/pnas.0608249103
  23. Nemeth K, Leelahavanichkul A, Yuen PST et al (2008) Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15, 42-49 https://doi.org/10.1038/nm.1905
  24. Zappia E, Casazza S, Pedemonte E et al (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106, 1755
  25. Kang I, Lee BC, Lee JY et al (2019) Interferon-$\gamma$-mediated secretion of tryptophanyl-tRNA synthetases has a role in protection of human umbilical cord blood-derived mesenchymal stem cells against experimental colitis. BMB Rep 52, 318-323 https://doi.org/10.5483/bmbrep.2019.52.5.134
  26. Ren G, Zhang L, Zhao X et al (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2, 141-150 https://doi.org/10.1016/j.stem.2007.11.014
  27. Krampera M, Glennie S, Dyson J et al (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101, 3722 https://doi.org/10.1182/blood-2002-07-2104
  28. Beyth S, Borovsky Z, Mevorach D et al (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 2214 https://doi.org/10.1182/blood-2004-07-2921
  29. Puissant B, Barreau C, Bourin P et al (2005) Immunomodulatory effect of human adipose tissue derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129, 118-129 https://doi.org/10.1111/j.1365-2141.2005.05409.x
  30. Yanez R, Lamana ML, Garcia Castro J, Colmenero I, Ramirez M and Bueren JA (2006) Adipose Tissue Derived Mesenchymal Stem Cells Have In Vivo Immunosuppressive Properties Applicable for the Control of the Graft Versus Host Disease. Stem Cells 24, 2582-2591 https://doi.org/10.1634/stemcells.2006-0228
  31. Sato K, Ozaki K, Oh I et al (2007) Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109, 228 https://doi.org/10.1182/blood-2006-02-002246
  32. Tse WT, Pendleton JD, Beyer WM, Egalka MC and Guinan EC (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389 https://doi.org/10.1097/01.TP.0000045055.63901.A9
  33. Kim HS, Shin TH, Lee BC et al (2013) Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2. Gastroenterology 145, 1392-1403 e1391-1398 https://doi.org/10.1053/j.gastro.2013.08.033
  34. Kim HS, Yun JW, Shin TH et al (2015) Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-beta1 alleviate atopic dermatitis by reducing mast cell degranulation. Stem Cells 33, 1254-1266 https://doi.org/10.1002/stem.1913
  35. Oh JY, Ko JH, Lee HJ et al (2014) Mesenchymal stem/stromal cells inhibit the NLRP3 inflammasome by decreasing mitochondrial reactive oxygen species. Stem Cells 32, 1553-1563 https://doi.org/10.1002/stem.1608
  36. Wang L, Chen K, Wan X, Wang F, Guo Z and Mo Z (2017) NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation. Biochem Biophys Res Commun 484, 871-877 https://doi.org/10.1016/j.bbrc.2017.02.007
  37. Wang H, Wang Y, Du Q et al (2016) Inflammasomeindependent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells. Exp Cell Res 342, 184-192 https://doi.org/10.1016/j.yexcr.2016.03.009
  38. Kim SM, Kim YG, Kim DJ et al (2018) Inflammasome- Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal Injury. Front Immunol 9, 2563 https://doi.org/10.3389/fimmu.2018.02563
  39. Bruchard M, Rebe C, Derangere V et al (2015) The receptor NLRP3 is a transcriptional regulator of TH2 differentiation. Nat Immunol 16, 859-870 https://doi.org/10.1038/ni.3202
  40. Opitz CA, Litzenburger UM, Lutz C et al (2009) Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells 27, 909-919 https://doi.org/10.1002/stem.7
  41. Waterman RS, Tomchuck SL, Henkle SL and Betancourt AM (2010) A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One 5, e10088 https://doi.org/10.1371/journal.pone.0010088